@Updock profile picture
JM Schussler, MD @Updock

#Radialfirst interventionalist, #Takotsubo enthusiast and Cardiology #Ethics. Research: bit.ly/2hVDLgl I ride a bit.ly/2r0QUVw bike.

Joined July 2008
  • Tweets 4,077
  • Following 1,951
  • Followers 2,020
183 Photos and videos
Pinned Tweet
JM Schussler, MD@Updock
30 Jun 2016
citoday.com/2016/06/transrad… @bswhealth @ThinkRadial
4
38
94
Cannabis use increases risk of death, heart attack for ED patients cardiovascularbusiness.com/t…

Cannabis use increases risk of death, heart attack for ED patients

When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.

cardiovascularbusiness.com
1
4
107
Stereotaxis to acquire robotic PCI company Robocath for up to $45M cardiovascularbusiness.com/t…

Stereotaxis to acquire robotic PCI company Robocath for up to $45M

The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.

cardiovascularbusiness.com
2
62
Doctors Who Use AI Perceived Less Favorably, Survey Suggests medpagetoday.com/practiceman…

Doctors Who Use AI Perceived Less Favorably, Survey Suggests

Surveyed adults thought AI-using doctors were less competent, trustworthy, empathetic

medpagetoday.com
3
65
Cannabis is bad for the heart—should the risk be taken more seriously? cardiovascularbusiness.com/t…

Cannabis is bad for the heart—should the risk be taken more seriously?

Use of the drug more than doubles a person's risk of dying from heart disease, according to a new analysis of 24 different studies. In a separate editorial, two physicians shared their concerns and...

cardiovascularbusiness.com
1
3
7
507
Robotic-Assisted Percutaneous Coronary Intervention: Final Results of ... sciencedirect.com/science/ar… Maybe a bit ahead of its time, but so glad the data got published. @RyanMadderMD @wohnsmd @ron_waksman @AlexandraLansky @Giora_Weisz_MD #DoTheRobot

1
1
8
152
Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients cardiovascularbusiness.com/t…

Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients

Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study, researchers explored data from more than...

cardiovascularbusiness.com
1
5
88
Cannabis Use Substantially Increases Risk of Heart Attack - American College of Cardiology acc.org/Latest-in-Cardiology…

Cannabis Use Substantially Increases Risk of Heart Attack - American College of Cardiology

acc.org
3
6
83
Cannabis use increases risk of heart attack, stroke in young adults cardiovascularbusiness.com/t…

Cannabis use increases risk of heart attack, stroke in young adults

“Asking about cannabis use should be part of clinicians' workup to understand patients' overall cardiovascular risk, similar to asking about smoking cigarettes,” one researcher said. Additional...

cardiovascularbusiness.com
1
3
76
Cannabis use increases risk of heart attack, stroke in young adults cardiovascularbusiness.com/t…

Cannabis use increases risk of heart attack, stroke in young adults

“Asking about cannabis use should be part of clinicians' workup to understand patients' overall cardiovascular risk, similar to asking about smoking cigarettes,” one researcher said. Additional...

cardiovascularbusiness.com
1
4
518
Choosing left radial access in the cath lab helps cardiologists limit radiation exposure cardiovascularbusiness.com/t… #radialfirst

Choosing left radial access in the cath lab helps cardiologists limit radiation exposure

Using a left radial artery approach in the cath lab exposes interventional cardiologists to significantly less radiation than a hyper-adducted right radial artery approach. The difference is substa...

cardiovascularbusiness.com
2
87
CABG still the ‘gold standard’ for revascularization in patients with 3-vessel CAD and CKD cardiovascularbusiness.com/t…

CABG still the ‘gold standard’ for revascularization in patients with 3-vessel CAD and CKD

The median follow-up period was more than nine years, allowing researchers to compare long-term outcomes after both CABG and PCI. 

cardiovascularbusiness.com
2
55
JM Schussler, MD retweeted
Ariane Lemieux@ArianeLemieuxMD
28 Jan 2025
Interesting Case at BHVH, we wrote up with @Updock and @HashemiHelen! Available fully online for the next month: authors.elsevier.com/a/1kNuq…
2
4
332
Yes, physicians warn, cannabis is bad for the heart cardiovascularbusiness.com/t… #journalofduh

Yes, physicians warn, cannabis is bad for the heart

Cannabis use is on the rise throughout the United States, but it is not as harmless as some people may believe. An in-depth analysis out of Stanford explored the many cardiovascular risks associated...

cardiovascularbusiness.com
3
96
JM Schussler, MD retweeted
Sunil V. Rao@SVRaoMD
22 Jan 2025
Very interesting study in @CircIntv on time to treatment in acute PE. Potentially a STEMI-like paradigm.
Robert Zhang MD@robertshiuzhang
22 Jan 2025
Curious about the impact of "door-to-RV unload time" in PE treated w/ percutaneous interventions? Dive into our latest article in @CircIntv to find out👇 🔗ahajournals.org/doi/10.1161/… & don't miss the insightful editorial by @sanjum ⤵️ 🔗ahajournals.org/doi/10.1161/… @SripalBangalore
2
7
56
7,461
FDA clears AI screening tool for cardiac amyloidosis cardiovascularbusiness.com/t… #AICardiology

FDA clears AI screening tool for cardiac amyloidosis

Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA's breakthrough device designation back in 2023.

cardiovascularbusiness.com
1
2
104
Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischemic cardiomyopathy: long-term survival academic.oup.com/eurheartj/a…

Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardio...

AbstractBackground and Aims. The optimal revascularization strategy in patients with ischaemic cardiomyopathy remains unclear with no contemporary randomiz

academic.oup.com
2
105
FDA clears AI tool that flags signs of heart disease in chest CT scans cardiovascularbusiness.com/t… #AICardiology

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients...

cardiovascularbusiness.com
1
2
103
Colchicine falls flat in large heart attack trial, convincing cardiologists to stay away cardiovascularbusiness.com/t… #thingsthatdontwork

Colchicine falls flat in large heart attack trial, convincing cardiologists to stay away

Treating AMI patients with colchicine is not associated with better cardiovascular outcomes, according to new data presented at TCT. The drug did help with inflammation, but that was the only benefit...

cardiovascularbusiness.com
1
2
108
FDA approves AI startup’s new software for echo assessments cardiovascularbusiness.com/t… #AICardiology

FDA approves AI startup’s new software for echo assessments

iCardio.ai, co-founded by a cardiologist, is part of the Cedars-Sinai Accelerator program. The startup has already announced new partnerships with Viz.ai, Abbott and others in the cardiac health...

cardiovascularbusiness.com
4
99
FDA grants AI-powered ECG screening tool for aortic stenosis its breakthrough device designation cardiovascularbusiness.com/t… #AICardiology

FDA grants AI-powered ECG screening tool for aortic stenosis its breakthrough device designation

The FDA clearly sees significant potential in this new screening software from New York-based AccurKardia.

cardiovascularbusiness.com
110
Load more